Customer login

Xellia Pharmaceuticals signs agreement with Mark Information


The agreement covers a standard ProMark solution for 600 employees in Denmark which will be implemented in 2 phases.

Xellia Pharmaceuticals

Xellia Pharmaceuticals has just signed an agreement with Mark Information on implementation of a standard ProMark solution for 600 employees in Denmark after a fairly comprehensive tendering process.

The solution will be implemented in 2 phases and includes:

  • Phase 1:
    – Time & Attendance and absence registration for the hourly-paid employees (ProTime)
    – Registration via portal and terminals (ProPortal and ProTerminal)
    – Automatic email notifications in case of missing registrations and/or approvals (ProNotify)
    – Integration to SAP SuccessFactors and Visma payroll (ProHost)
    – Absence analysis (ProAbs)
    – Web-based staff roster planning (ProRoster)
  • Phase 2:
    – Mobile registration via our app with a self-service opportunity (ProMobile)

The project will start up at the end of October.

About Xellia Pharmaceuticals
Xellia Pharmaceuticals s a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Headquartered in Copenhagen, Denmark and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1500 employees globally.